SPDR SSgA多資產實際回報ETF RLY 深 滬
等待開盤 10-21 09:30:00 美东时间
31.38
+0.330
+1.06%
華盛通- 最 高31.38
- 今 開31.17
- 成交量 4.23万股
- 最 低 31.17
- 昨 收 31.05
- 總市值 5.38亿
- 52周最高 31.44
- 市盈率 靜 --
- 換手率 0.25%
- 52周最低 25.2801
- 委 比 -20.00%
- 總股本 1713.00万
- 歷史最高 31.44
- 量 比 0.45
- 振 幅 0.68%
- 歷史最低 6.9138
- 每 手 1
- 風險率 1.27%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多KYNDRYL TO RELEASE QUARTERLY RESULTS ON NOVEMBER 4, 2025
Company will host earnings call on November 5, 2025 NEW YORK, Oct. 16, 2025 /PRNewswire/ -- Kyndryl (NYSE: KD), a leading provider of mission-critical enterprise technology services, today a...
10-17 04:30
PENSKE AUTOMOTIVE GROUP ANNOUNCES $0.06 INCREASE IN QUARTERLY DIVIDEND
Represents 20th Consecutive Quarterly Increase BLOOMFIELD HILLS, Mich., Oct. 15, 2025 /PRNewswire/ -- Penske Automotive Group, Inc. (NYSE: PAG), a diversified international transportation se...
10-16 04:04
VULCAN DECLARES QUARTERLY DIVIDEND ON COMMON STOCK
BIRMINGHAM, Ala., Oct. 10, 2025 /PRNewswire/ -- The Board of Directors of Vulcan Materials Company (NYSE: VMC) today declared a quarterly cash dividend of $0.49 per share on its common stock...
10-11 04:30
KalVista Pharmaceuticals Presents Data From KONFIDENT Studies On EKTERLY For Hereditary Angioedema, Highlights Need For Oral Alternatives To Injectable Therapies
Findings from KONFIDENT and KONFIDENT-S show rapid, effective treatment of HAE attacks among European participants; patient survey highlights barriers linked to injectable therapiesKalVista Pharmaceuticals, Inc.
10-07 04:03
CF BANKSHARES INC., PARENT OF CFBANK, NA, ANNOUNCES QUARTERLY CASH DIVIDEND
COLUMBUS, Ohio, Oct. 1, 2025 /PRNewswire/ -- CF Bankshares Inc. (NASDAQ: CFBK) (the "Company"), the parent of CFBank, NA, today announced that the Board of Directors of the Company declared ...
10-01 21:00
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director
Royalty Pharma announced Dr. Ted W. Love as Lead Independent Director. With extensive biopharma experience, Love will continue to Chair the Nominating and Corporate Governance Committee. Love has served as BIO's Immediate Past Chairman and previously led Global Blood Therapeutics and Onyx Pharmaceuticals. Royalty Pharma, the largest biopharma royalties purchaser, aims to accelerate life sciences innovation. Royalty Pharma has assembled a portfol...
09-29 12:15
SM ENERGY DECLARES QUARTERLY CASH DIVIDEND
DENVER, Sept. 25, 2025 /PRNewswire/ -- SM Energy Company (NYSE: SM) today announces that its Board of Directors approved the quarterly cash dividend of $0.20 per share of common stock outsta...
09-26 04:15
PREFORMED LINE PRODUCTS ANNOUNCES QUARTERLY DIVIDEND
CLEVELAND, Sept. 18, 2025 /PRNewswire/ -- The Board of Directors of Preformed Line Products (Nasdaq: PLPC) on September 18, 2025, declared a regular quarterly dividend in the amount of $.20 ...
09-19 04:15
Washington Trust Bancorp, Inc. Announces Quarterly Dividend
WESTERLY, R.I., Sept. 18, 2025 /PRNewswire/ -- The Board of Directors of Washington Trust Bancorp, Inc., (Nasdaq:WASH), today declared a quarterly dividend of 56 cents per share for the quar...
09-18 23:00
Autolus Therapeutics Announces Online Publication Of An Abstract For The Upcoming ACR Convergence 2025 Conference. The Company Will Present A Poster With Updated Follow-up Data From Its Carlysle Study In Patients With Severe Refractory Systemic Lupus Erythematosus
Autolus Therapeutics plc (NASDAQ:AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces the online publication of
09-16 20:10
